戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 secondary glaucoma (47% vs. 15%; P < 0.001), iris neovascularization (46% vs. 22%; P < 0.001), ectrop
2 her phenotypical measurements, including (1) iris transillumination grading, (2) retinal layer measur
3 te of poor vision (</=20/200) (46% vs. 12%), iris (20% vs. 4%) or ciliary body (30% vs. 8%) lymphoma,
4 on complications included cataract (n = 13), iris telangiectasia (n = 5), corneal epithelial defect (
5                                      The 160 iris melanomas were too few for subgroup analysis.
6 cluded anterior chamber seeds (n = 25, 17%), iris infiltration (n = 12, 8%), ciliary body infiltratio
7 s included secondary glaucoma (n = 18, 44%), iris neovascularization (n = 21, 51%), cataract (n = 19,
8  eyes, 0.27%), suction loss (5 eyes, 0.45%), iris hemorrhage (1 eye, 0.09%), and endothelial incision
9 y body and/or ciliary muscle (7 eyes [58%]), iris (6 eyes [50%]), and cornea (4 eyes [33%]).
10 es included dermal (n = 6), scleral (n = 9), iris (n = 3), and palate (n = 1) melanocytosis.
11 terior segment abnormalities included absent iris crypts, iris transillumination, lens subluxation, a
12 er depth (ACD), anterior chamber area (ACA), iris thickness (IT), iris area, iris curvature, lens vau
13 r area (ACA), anterior chamber volume (ACV), iris curvature (I-Curv), iris area (I-Area), lens vault
14      Patients were examined before and after iris reconstruction with the iris implant placed in the
15                                          All iris devices were in the correct position, and all eyes
16 is lesions, including freckles, nevi, and an iris pigment epithelial (IPE) cyst, were imaged.
17 umented first occurrence of bleeding from an iris vascular tuft.
18 cal tilting and rotation in TM1 generates an iris-like motion that increases the diameter of the perm
19  exchange with retropupillary fixation of an iris-claw IOL (n = 50).
20 stalline lenses involving preplacement of an iris-sutured posterior chamber intraocular lens (PCIOL)
21 etic to the channel were found to promote an iris-like conformational change that constricts and dehy
22                                      When an iris lesion occurs in a pediatric patient, it can be dif
23 as never been described in a patient with an iris prosthesis.
24 erative endophthalmitis in a patient with an iris prosthesis.
25 patients with a PCIOL, and 1 patient with an iris-fixated PCIOL.
26 cluded choroid (88%), ciliary body (2%), and iris (10%), with bilateral involvement in 18%.
27    The changes in angle parameters, ACA, and iris curvature were not significantly different between
28 ify in the context of traumatic aniridia and iris prosthesis implantation due to other potential etio
29 my; secondary implantations for aphakia; and iris suture fixation at primary cataract extraction.
30 cyclectomy for iris melanoma in 15 cases and iris adenoma in 1 case underwent prosthetic iris device
31 y retinal pigment epithelial (RPE) cells and iris pigment epithelial (IPE) cells stimulated with lipo
32  genes incorporate into the lens, cornea and iris, and the eye placode is the sole source of retinal
33 olvement, largest basal tumour diameter, and iris colour.
34 ebellar ataxia, intellectual disability, and iris hypoplasia.
35 n patients with existing scleral-fixated and iris-fixated intraocular lenses (sf-IOL and if-IOL, resp
36                             Iris furrows and iris color were not associated with iris volume in light
37  loss of pigmentation in the skin, hair, and iris.
38 and IOL, the slope ratio between the IOL and iris, IOL tilt, and optic surface changes were determine
39 ut there was no significant change in IT and iris area.
40 ntraocular tissues (aqueous humor, lens, and iris) versus eyes not receiving Y-27632 pretreatment.
41 lenses, iris- or scleral-sutured lenses, and iris-claw lenses.
42 anterior segment and on the IOL surface, and iris transillumination defects.
43 iris melanoma, combined cataract surgery and iris prosthesis placement, with or without iris reconstr
44 th corneal clouding, anterior synechiae, and iris hypoplasia.
45 ), trabecular iris space area (TISA750), and iris thickness (IT750) at 750 mum from the scleral spur.
46 anterior to the scleral spur to the anterior iris surface (AOD500 and AOD750, respectively), and ante
47  area (ACA), iris thickness (IT), iris area, iris curvature, lens vault (LV), anterior vault, angle o
48                                   Artificial iris anterior chamber implants are associated with sight
49                                   Artificial iris anterior chamber implants were originally developed
50 on after implantation of this new artificial iris prosthesis.
51           The implantation of the artificial iris is a new and effective therapeutic option for the t
52 f retropupillary implantation of the Artisan iris-claw intraocular lens (RPICIOL) in several aphakic
53  iris racemose hemangioma without associated iris or ciliary body solid tumor on clinical examination
54 OCTA) in malignant iris melanomas and benign iris lesions.
55 omas (34.5%+/-9.8%, P < 0.05) than in benign iris nevi (8.0%+/-1.4%) or normal irides (8.0%+/-1.2%).
56 and 9 patients with iris melanomas or benign iris lesions, including freckles, nevi, and an iris pigm
57 e also investigated the relationship between iris abnormalities and other phenotypical features of al
58  to fully elucidate the relationship between iris insertion and angle closure development.
59 e abnormalities in 8 eyes (47.1%), bilateral iris coloboma in 1 patient (2 eyes [11.8%]), and lens su
60  syndrome (GS) is characterized by bilateral iris hypoplasia, congenital hypotonia, non-progressive a
61       We report a case notable for bilateral iris and ciliary body cysts--a rare presentation of the
62 ared ocular manifestations include bilateral iris hypoplasia, ectopia lentis, corectopia, ectropion u
63 ment of the eye, including the ciliary body, iris, and cornea.
64 iction), or severe (billowing accompanied by iris prolapse and >/=2 mm of pupil constriction).
65 ignificantly expressed gene EPYC might cause iris lesion in MD.
66 ccessfully achieving placement of a centered iris-sutured PCIOL in patients with follow-up of longer
67 quate capsular support had posterior chamber iris-claw aphakic IOL implantation between 2007 and 2012
68 f the anterior structures (anterior chamber, iris, ciliary body/muscle) was detected significantly mo
69 syndrome typically manifests with congenital iris pigmentary abnormalities, but careful inspection ca
70 fication tools was used to image the cornea, iris, and natural lens preoperatively and intraocular le
71  malformations, unicoronal craniosynostosis, iris colobomas, microphthalmia, and intestinal malrotati
72 t abnormalities included absent iris crypts, iris transillumination, lens subluxation, and cataract.
73 amber volume (ACV), iris curvature (I-Curv), iris area (I-Area), lens vault (LV), and angle opening d
74 ncrease in ACA was mainly owing to decreased iris curvature.
75 loping and championing the use of deliberate iris inclusion into the filtering sclerotomy (iridenclei
76 anch molluscs Melibe leonina and Dendronotus iris exhibit homologous swimming behaviors, consisting o
77 medea, Tochuina tetraquetra, and Dendronotus iris, the number of GABA-ir neurons was highly consisten
78 itonia diomedea, Melibe leonina, Dendronotus iris, and Hermissenda crassicornis.
79 and greater baseline anterior chamber depth, iris curvature, and lens vault (P </= 0.002 for all).
80 t, including 11.7% of patients who developed iris neovascularisation (INV) and 8.3% of patients who d
81                                      Diffuse iris melanoma showed a higher risk of relapse (P = 0.044
82                                      Digital iris photographs were taken from eyes of each participan
83 tructures, and a hypoplastic or disorganized iris were also observed in the 3 cases.
84 50X)) are responsible for pigment dispersing iris disease, which progresses to intraocular pressure (
85  signals in the optic nerve ultimately drive iris-sphincter-muscle contraction via excitatory choline
86 lowing only), moderate (billowing and either iris prolapse or >/=2 mm of pupil constriction), or seve
87 s, as does the inability to image the entire iris in a single field.
88 tion of the PCIOL, and 1 patient experienced iris capture of the PCIOL after surgery.
89           In both APAC eyes and fellow eyes, iris curvature decreased after LPI (P < .001).
90 n and the occurance of intraoperative floppy iris syndrome.
91                                        Focal iris thinning/atrophy was detected by ultrasound biomicr
92 17 eyes) who underwent placement of foldable iris-sutured PCIOLs between September 2004 and September
93      A retrospective study was conducted for iris melanoma patients from 3 regional ophthalmologic ce
94 Cancer, eighth edition, staging criteria for iris melanoma, 21 tumors (42%) were T1a, 5 tumors (10%)
95 age, 59.8+/-5.7 years) had gradable data for iris surface features.
96  with iris defects after iridocyclectomy for iris melanoma in 15 cases and iris adenoma in 1 case und
97 ry in eyes with previous iridocyclectomy for iris melanoma or presumed iris melanoma.
98  of the tumor from the optic nerve or fovea, iris involvement, extrascleral extension, or tumor pigme
99 t reported case of spontaneous hyphaema from iris vascular tuft related to a documented supratherapeu
100  Three infants (aged 1, 6, and 8 months) had iris neovascularization, 2 had anterior ciliary body tum
101                   In light condition, higher iris crypt grade was associated independently with small
102 llowing an injection at an outside hospital, iris depigmentation and thinning, iris recession with re
103 ve non-HLA genes were all expressed in human iris tissue.
104 limitations in the characterization of human iris pigmentation, we introduce a fully automated approa
105 is report, we used primary cultures of human iris stroma (HIS) cells derived from human eye donors to
106  iris volume in light condition or change in iris volume (all P > 0.05).
107                Associations of the change in iris volume after pupil dilation with underlying iris su
108 ly with smaller iris volume (beta [change in iris volume in millimeters per crypt grade increment] =
109 is volume on pupil dilation (beta [change in iris volume in millimeters per crypt grade increment] =
110 om semiautomated software, and the change in iris volume was quantified.
111 apy showed efficacy and limited morbidity in iris melanomas.
112   This is the first demonstration of OCTA in iris tumors.
113 or monitoring a variety of tumors, including iris melanocytic lesions, for growth and vascularity.
114  36% for the compressible and incompressible iris, respectively.
115 CA and a more anteriorly curved and inserted iris than those of the full-term children.
116 iris curvature, and more anteriorly inserted iris than those of the full-term children (P < .001, P =
117 tive and nonselective), IFIS, intraoperative iris trauma, intraoperative iris prolapse, posterior cap
118 , intraoperative iris trauma, intraoperative iris prolapse, posterior capsular tear, anterior capsule
119 ior chamber area (ACA), iris thickness (IT), iris area, iris curvature, lens vault (LV), anterior vau
120 tion revealed CPAMD8 expression in the lens, iris, cornea, and retina early in development, including
121     Choices include anterior chamber lenses, iris- or scleral-sutured lenses, and iris-claw lenses.
122 rix nattereri) and opal-crowned (Lepidothrix iris) manakins of the Amazon basin, leading to the forma
123 ter >15 mm HR: 7.0 (95% CI: 3.5-13.9), light iris colour (HR: 2.3 (95% CI: 0.9-5.8), having children
124 nd the established prognostic factors, light iris colour also appears to be a prognostic factor for d
125 lor parameter (higher value denoting lighter iris).
126 ight, +/-2 mm) and anterior margin location (iris, ciliary body, pre-equatorial or postequatorial cho
127  heterozygous null mutations showed no major iris defects.
128 e tomography angiography (OCTA) in malignant iris melanomas and benign iris lesions.
129  or timing of Gpnmb(R150X) Tyrp1(b) mediated iris disease.
130 filament) near the pupil (n = 3) or midzonal iris (n = 1), before returning to the peripheral iris (b
131 nopsin expression in a small subset of mouse iris sphincter muscle cells, with the light-induced cont
132 55 mmHg, with a 1.6 mm hyphaema and multiple iris vascular tufts visible around the entire pupil.
133 ears to be the first to demonstrate multiple iris and ciliary body cysts with high-quality color phot
134 ic (Ophtec B.V., Groningen, The Netherlands) iris-fixated pIOL for the treatment of myopia or astigma
135         Penetration of flow signal in normal iris depended on iris color, with best penetration seen
136                                   The normal iris has radially oriented vessels within the stroma on
137 ngioma course and its relation to the normal iris microvasculature.
138 ity, were significantly correlated to AS-OCT iris thickness measurements.
139 the need for Ophthalmologists to be aware of iris vascular tufts as a cause for spontaneous hyphaema,
140              In an analysis of 1611 cases of iris nevus referred for evaluation at an ocular oncology
141                Qualitative classification of iris insertion into basal, middle, and apical categories
142 y that clearly depicts the looping course of iris racemose hemangioma.
143  patients experienced metastases nor died of iris melanoma.
144      Furthermore, we assess of the effect of iris colour and having children on 5-year risk of death
145 T and OCTA images, qualitative evaluation of iris and tumor vasculature, and quantitative vessel dens
146                                  Features of iris racemose hemangioma on OCTA.
147                 To describe OCTA features of iris racemose hemangioma.
148  is difficult may consist of implantation of iris prostheses, devices designed to reduce symptoms of
149 functional results following implantation of iris prosthesis combined with cataract surgery in eyes w
150  pigmentation, and vascularity; incidence of iris neovascularization; and radiation-related complicat
151                                 Placement of iris-sutured PCIOLs at the time of subluxated lens extra
152 eficiency, as critical in the progression of iris disease and glaucoma.
153 rophylaxis significantly reduced the rate of iris rubeosis from 36% to 4% (log-rank test P = .02) and
154 o -0.59; P = 0.001) and greater reduction of iris volume on pupil dilation (beta [change in iris volu
155    To evaluate the patterns of regression of iris melanoma after treatment with palladium-103 ((103)P
156 on and absolute alcohol-induced sclerosis of iris stromal cysts is safe and effective, with cyst invo
157 correlation (P = 0.000) between the slope of iris and the IOL in horizontal and vertical axes.
158  to classify because of the wide spectrum of iris proliferations.
159 novative device in the surgical treatment of iris defects.
160 y angiography (OCTA) allows visualization of iris racemose hemangioma course and its relation to the
161 on of flow signal in normal iris depended on iris color, with best penetration seen in light to moder
162 ing the choroid (90%), ciliary body (7%), or iris (2%).
163 8/1059, 89%), ciliary body (85/1059, 8%), or iris (36/1059, 3%), with 19% being macular in location.
164 e were no reports of neovascular glaucoma or iris neovascularization.
165 EGF are elevated in patients with retinal or iris neovascularization, and VEGF-specific antagonists m
166 ntify the best medical practice in pediatric iris lesions with atypical characteristics.
167 (filament sign), arising from the peripheral iris (base of light bulb) and forming a tortuous loop on
168  (n = 1), before returning to the peripheral iris (base of light bulb).
169 ation (LS) pupillary block (PB), and plateau iris syndrome (PL).
170  enlarged Soemmering ring provided posterior iris support in apposition to the anterior chamber angle
171 ergone previous iridocyclectomy for presumed iris melanoma, combined cataract surgery and iris prosth
172 ridocyclectomy for iris melanoma or presumed iris melanoma.
173 E PRESENTATION: Two patients with a previous iris-claw PIOL implantation were enrolled.
174  the diagnosis for 3217, and 160 had primary iris melanoma.
175                                   Prosthetic iris implantation was combined with phacoemulsification
176 er implantation of the Ophtec 311 prosthetic iris.
177 dual iris or opaque portions of a prosthetic iris device.
178  iris adenoma in 1 case underwent prosthetic iris device implantation surgery.
179 stics superimposed over small-caliber radial iris vessels against a background of low-signal iris str
180 is hemangioma; however, small-caliber radial iris vessels were more distinct on OCTA than intravenous
181  angiography depicted fine details of radial iris vessels, not distinct on intravenous fluorescein an
182                 Iris vascular tufts are rare iris stromal vascular hamartomas.
183 e extraocular relapse of previously resected iris melanoma, without concurrent intraocular recurrence
184 extraocular relapse from previously resected iris melanoma.
185 bconjunctival relapse of previously resected iris melanoma.
186 were covered in all areas by either residual iris or opaque portions of a prosthetic iris device.
187 n = 54) or IOL exchange with a retropupillar iris-claw lens (n = 50).
188 ) after the implantation of 2 types of rigid iris-fixated phakic intraocular lenses (pIOLs) for the t
189 0X) Tyrp1(b) strain, which develops the same iris disease as DBA/2J mice.
190                        All eyes had sectoral iris racemose hemangioma without associated iris or cili
191 d as the presence of anterior chamber seeds, iris infiltration, ciliary body infiltration, massive (>
192 d as the presence of anterior chamber seeds, iris infiltration, ciliary body/muscle infiltration, mas
193 s vessels against a background of low-signal iris stroma.
194           The custom-made, flexible silicone iris prosthesis ArtificialIris (HumanOptics, Erlangen, G
195 print contact lenses, sunglasses, and simple iris prostheses.
196 de was associated independently with smaller iris volume (beta [change in iris volume in millimeters
197 t effect ORs were adjusted for age, smoking, iris pigmentation, self-reported cardiovascular disease,
198               Our examination revealed solid iris tumor (n = 3), ciliary body involvement (n = 2), an
199                               This stability iris mechanism likely contributes to the narrowing of ra
200 P children exhibited a narrower ACA, steeper iris curvature, and more anteriorly inserted iris than t
201 gns (fine nystagmus in 2 patients and subtle iris transillumination in 5 patients).
202                The management of symptomatic iris stromal cyst is challenging using methods of aspira
203                                     Temporal iris therefore may be considered a preferred location fo
204 scans, 50 B-scans) of the nasal and temporal iris in both eyes using AS-OCT (3-mum axial resolution).
205                                          The iris lesion was treated with topical (18/21, 86%) and/or
206                                          The iris showed diffuse pigmentation in 10 cases and sectori
207                                          The iris stromal cysts were primary congenital (n = 6), prim
208                                          The iris tumor was nodular (16/21, 76%) or diffuse (5/21, 24
209                                          The iris-free procedure of corneoscleral trephination develo
210                                          The iris-like channel opening is accompanied by an alpha-to-
211 optic (D1, D2), slope of the line across the iris and IOL, the slope ratio between the IOL and iris,
212 n the parasympathetic pathway activating the iris sphincter and ciliary muscle to mediate pupillary c
213        Ocular JXG preferentially affects the iris and is often isolated without cutaneous involvement
214 vent was adhesion between the cornea and the iris (synechia; n = 24).
215       The mean angle between the IOL and the iris was noted to be 3.2 +/- 2.7 degrees and 2.9 +/- 2.6
216  and folding translucent membrane behind the iris (stage 3), and a broad membrane within the pupil (s
217                     The distance between the iris margin and the anterior IOL optic (D1, D2), slope o
218  angiography performed in 1 eye depicted the iris hemangioma; however, small-caliber radial iris vess
219 - and agonist-bound states and determine the iris-like mechanism of ion channel opening.
220 fficiency of CD94 failed to alter either the iris disease or the subsequent IOP elevation.
221                            In APAC eyes, the iris flattened, cACD deepened, and the lens shifted post
222 of the retinal neuroepithelium that form the iris and ciliary body, thus correlating CPAMD8 expressio
223 tumors (n = 6/61; 9.5%) originating from the iris and ciliary body required muscle surgery for plaque
224 xpression of ZIKV antigen was present in the iris in cases 1, 3, and 4; the neural retina and choroid
225                                       In the iris JXG group, mean IOP was 19 mmHg (median, 18 mmHg; r
226 presence and effector pathway locally in the iris remain uncertain.
227 75% of the eyes 1 haptic was embedded in the iris; it extended into the ciliary body process in 35% a
228 e ocular tissue affected by JXG included the iris (21/31, 68%), conjunctiva (6/31, 19%), eyelid (2/31
229 s of ocular cells and tissues, including the iris region of the uveal tract during anterior uveitis.
230 tion defined by total or partial loss of the iris and leads to decreased visual quality marked by gla
231 with increased axial length, coloboma of the iris and of the optic disc, and severe myopia.
232 e characterized in vivo abnormalities of the iris associated with albinism for the first time and sho
233  immune components in the progression of the iris disease and high IOP.
234 h, ACD, and ACA as well as flattening of the iris in APAC eyes.
235 croscopic and microscopic composition of the iris is a contributing feature to angle-closure disease.
236                        Upon follow-up of the iris JXG group, visual acuity was stable or improved (18
237 t disorder characterized by inability of the iris to dilate owing to absence of dilator pupillae musc
238  included ptosis, esotropia, coloboma of the iris, retina, choroid and optic disc, and microcornea.
239 hree cases because of slippage of one of the iris-claw haptics and spontaneous complete posterior dis
240 ients with primary malignant melanoma of the iris.
241 h tumor seeding in the angle (38%) or on the iris stroma (25%).
242              This analysis revealed that the iris-like expansion of the transmembrane helices mainly
243 apupillary transmission of light through the iris and sclera.
244 ing to the eye's ciliary body or even to the iris [20-22].
245       Imaging of structures posterior to the iris is possible only with UBM.
246 e adhesions from the opacified cornea to the iris with a kerato-irido-lenticular contact to the remna
247 s descended from surface ectoderm, while the iris and collagen-rich stroma of the cornea have a neura
248 he direct apposition of the implant with the iris and iridocorneal angle, together with pressure-indu
249 efore and after iris reconstruction with the iris implant placed in the ciliary sulcus.
250 umelanin, and non-pigmented areas within the iris.
251  after more than 2 post-operative years, the iris prosthesis was explanted, and intravitreal cultures
252  hospital, iris depigmentation and thinning, iris recession with retinal necrosis and hypotony, a fil
253  in the aqueous humor and the target tissue (iris-ciliary body) up to 24weeks.
254          The most common findings related to iris melanoma regression after (103)Pd plaque brachyther
255 rted after implantation with myopic or toric iris-fixated pIOLs.
256 ng distance (AOD500, AOD750), and trabecular iris space area (TISA500, TISA750) were measured in qual
257 in AOD750, angle recess area, and trabecular iris surface area (P < 0.05 for all).
258  angle opening distance (AOD750), trabecular iris space area (TISA750), and iris thickness (IT750) at
259                                   Trabecular-iris angle (TIA) and angle opening distance 500 mum ante
260                                   Trabecular-iris angle (TIA), angle opening distance 500 mum from th
261                                   Trabecular-iris contact (TIC) was observed in 8 eyes of 8 subjects,
262 gle opening distance (AOD500) and trabecular-iris space area (TISA500) 500 mum from the scleral spur,
263 ers angle opening distance (AOD), trabecular-iris space area (TISA), trabecular-iris circumference vo
264  iridocorneal angle measurements: trabecular-iris angle (TIA), angle opening distance (AOD500) and tr
265 m (AOD750) from the scleral spur; trabecular-iris space area at 500 mum (TISA500) and 750 mum (TISA75
266  anterior from scleral spur), the trabecular-iris-space area (TISA, measured 500 and 750 mum anterior
267 rabecular-iris space area (TISA), trabecular-iris circumference volume (TICV), length of iridotrabecu
268 d a contiguous ring of pigmented translucent iris cysts at the pupillary margin of each eye, confirme
269 n for the treatment of distinctive traumatic iris defects and results in an individual, aesthetically
270                          Patients undergoing iris melanoma resection are at risk of developing late s
271  volume after pupil dilation with underlying iris surface features in right eyes were assessed using
272 female patients and 1 male patient underwent iris tumor resection and presented to our service with s
273 subluxated intraocular lenses that underwent iris suture fixation at an academic institutional care c
274           Patients diagnosed with unilateral iris racemose hemangioma were included in the study.
275      Four eyes of 4 patients with unilateral iris racemose hemangioma were included in the study.
276 e ocular involvement: enophthalmos, uveitis, iris atrophy.
277  report on an unusual case of a vascularized iris lesion in a three year old Caucasian patient, with
278 ble of engrafting on the highly vascularized iris.
279                      Referring diagnosis was iris melanoma (n = 1), infectious endotheliitis (n = 1),
280 1), and the initial finding by physician was iris tumor (n = 2) or hyphema (n = 1).
281                 The parameters included were iris area, anterior chamber depth (ACD), anterior chambe
282 il recently, possible treatment options were iris print contact lenses, sunglasses, and simple iris p
283        Five patients (n = 5/161 [3.1%]) with iris melanoma demonstrated local recurrence and 1 metast
284 dy and choroidal (CBC) melanoma and 160 with iris melanoma were evaluated.
285 rows and iris color were not associated with iris volume in light condition or change in iris volume
286 ing progresses centrally in association with iris movement and aqueous flow.
287 ght and by tumor location (least atypia with iris tumors).
288 ants and formula for aphakia correction with iris-claw IOLs to achieve the best refractive status in
289 ures of the 2 groups revealed more eyes with iris neovascularization in the enucleation group (25.4%)
290              Sixteen patients (16 eyes) with iris defects after iridocyclectomy for iris melanoma in
291                                Patients with iris defects suffer from severe visual impairment, espec
292                                Patients with iris lesions and healthy volunteers.
293              One hundred seven patients with iris melanoma from 3 regional ophthalmologic centers.
294 aracteristics and outcomes for patients with iris melanoma using proton therapy.
295 h of 8 normal volunteers and 9 patients with iris melanomas or benign iris lesions, including freckle
296                            Two patients with iris transillumination had glaucoma.
297                                Patients with iris vascular tufts generally remain asymptomatic until
298                                   Those with iris JXG presented at a median age of 13 months compared
299 ssel density was significantly higher within iris melanomas (34.5%+/-9.8%, P < 0.05) than in benign i
300 d iris prosthesis placement, with or without iris reconstruction, can lead to visual improvement as w

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top